-+ 0.00%
-+ 0.00%
-+ 0.00%
Vistin Pharma ASA: Second quarter and YTD 2026 financial results
Share
Listen to the news

Oslo, Norway, 20 August 2026

Vistin Pharma ASA (VISTN) today announces its financial results for the second quarter and first half of 2026.

Revenue in the second quarter amounted to MNOK 100, compared to MNOK 118 in Q2 2025. Sales volume increased by 8%, offset by a significantly stronger NOK against EUR in the quarter compared to 2025, impacting sales in local currency.

Read more at globenewswire.com

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending